We have identified a novel human protein that is highly homologous to aldose reductase (AR). This protein, which we called ARL-1, consists of 316 amino acids, the same size as AR, and its amino acid sequence is 71% identical to that of AR. It is more closely related to the AR-like proteins such as mouse vas deferens protein, fibroblast growth factor-regulated protein, and Chinese hamster ovary reductase, with 81, 82, and 83%, respectively, of its amino acid sequence identical to the amino acid sequence of these proteins. The cDNA of ARL-1 was expressed in Escherichia coli to obtain recombinant protein for characterization of its enzymatic activities. For comparison, the cDNA of human AR was also expressed in E. coli and analyzed in parallel. These two enzymes differ in their pH optima and salt requirement, but they act on a similar spectrum of substrates. Similar to AR, ARL-1 can efficiently reduce aliphatic and aromatic aldehydes, and it is less active on hexoses. While AR mRNA is found in most tissues studied, ARL-1 is primarily expressed in the small intestines and in the colon, with a low level of its mRNA in the liver. The ability of ARL-1 to reduce various aldehydes and the locations of expression of this gene suggest that it may be responsible for detoxification of reactive aldehydes in the digested food before the nutrients are passed on to other organs. Interestingly, ARL-1 and AR are overexpressed in some liver cancers, but it is not clear if they contribute to the pathogenesis of this disease.
Aldose reductase (AR)1 is a NADPH-dependent enzyme that was first identified by its ability to reduce glucose to sorbitol (1). There are strong indications that it is involved in diabetic complications (2). However, its physiological function is not entirely clear. It is quite abundant in the epithelial cells lining the collecting tubules in the renal medullar. Since hyperosmotic stress can induce the transcription of AR, followed by the accumulation of sorbitol to a level that can affect intracellular osmotic pressure, it was proposed that AR may be involved in the osmoregulation in the kidney (3). In the seminal vesicles, AR may be involved in the production of fructose that is abundant in the semen because sorbitol can be converted to fructose by sorbitol dehydrogenase (1).Besides kidney and testes, AR is present in many other tissues where its function is not clear. Interestingly, glucose is not its preferred substrate (K m ϭ 100 mM, k cat /K m ϭ 2.8 ϫ 10 2 M Ϫ1 min Ϫ1 ) (5). It is more efficient in reducing various aromatic and aliphatic aldehydes including glyceraldehyde, benzaldehyde, pyridine aldehyde etc. (6). In particular, AR's ability to reduce methylglyoxal (K m ϭ 7.8 M, k cat /K m ϭ 1.8 ϫ 10 7 M Ϫ1 min Ϫ1 ) (7), a toxic byproduct of glucose metabolism, and 4-hydroxynonenal (K m ϭ 22 M, k cat /K m ϭ 4.6 ϫ 10 6 M Ϫ1 min Ϫ1 ) (8), a toxic lipid aldehyde produced during oxidative stress, suggests that it may be responsible for detoxifying these and other harmful aldehydes generated by cellular metaboli...